摘要
中国糖尿病治疗面临巨大挑战，传统降糖药物磺脲类应用于临床60余年，具有降糖疗效显著、安全性良好、不良反应明确、性价比高等特点，对于糖尿病管理仍有较高临床价值。
The clinical practice of diabetes management is facing challenge in China, old anti-diabetic drugs such as sulfonylureas have been used for more than 60 years, and they are still valuable in diabetes management because of their remarkable hypoglycemic effect, as well as good safety, clear adverse events and cost-effectiveness.
出处
《中华内分泌代谢杂志》
CAS
CSCD
北大核心
2017年第11期915-919,共5页
Chinese Journal of Endocrinology and Metabolism
关键词
临床实践
糖尿病
磺脲类
Clinical practice
Diabetes mellitus
Sulfonylureas
